Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 675 of 994 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/08/13
End: 11/04/16
Due: 11/04/17
Phase: N/A
Priority: Normal
Start: 01/02/12
End: 08/05/19
Due: 08/05/20
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 11/27/28
Due: 11/27/29
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/09/14
End: 01/22/15
Due: 01/22/16
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 03/21/22
End: 07/17/22
Due: 07/17/23
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 12/12/17
End: 04/05/18
Due: 04/05/19
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/19/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/05/17
End: 03/20/22
Due: 03/20/23
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants
Phase: N/A
Priority: Normal
Start: 12/21/09
End: 04/11/11
Due: 04/11/12
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 06/12/18
End: 10/31/20
Due: 10/31/21
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 09/30/03
Due: 09/30/04
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 09/13/22
End: 12/19/23
Due: 12/19/24
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 03/30/12
End: 11/21/12
Due: 11/21/13